SCHEMBL21347384

SCHEMBL21347384

CCCc1c(CCC(C)(C)C)sc(NC(=O)c2cncc(Br)c2)c1C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.42
▸ RAB9A P51151 7/20 0.42
▸ LMNA P02545 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ CACNA1I Q9P0X4 1/20 0.41
▸ SMN1; SMN2 Q16637 7/20 0.39
▸ HTT P42858 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ TSHR P16473 1/20 0.39
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ GAA P10253 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21347385 0.68 MAPT (0.72) NPC1RAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL26296832 0.67 CYP1A2 (0.43) NPC1RAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL21347434 0.66 ALDH1A1 (0.62) NPC1RAB9AKDM4ESMN1; SMN2HTT
SCHEMBL31137907 0.64 POLB (0.67) NPC1RAB9AKDM4ESMN1; SMN2HTT
SCHEMBL578591 0.64 POLB (0.67) NPC1RAB9AKDM4ESMN1; SMN2HTT
SCHEMBL3824227 0.63 KDM4E (0.69) NPC1RAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL758123 0.63 KDM4E (1.00) NPC1RAB9AKDM4ESMN1; SMN2HTT
SCHEMBL31418070 0.63 KDM4E (1.00) NPC1RAB9AKDM4ESMN1; SMN2HTT
Hydrochloric Acid SCHEMBL31575651 0.62 POLB (0.64) NPC1RAB9AKDM4ESMN1; SMN2HTT
SCHEMBL16891539 0.62 POLB (0.51) NPC1RAB9AKDM4ECACNA1ISMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019173437-A1 POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2019-09-12 — — WO disclosed
Send feedback